This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: The First Affiliated Hospital, Third Military University, Pla, Tianjin Chase Sun Pharmaceutical Co., Ltd. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Kecen Zhao: Innovator in Pharmaceutical Applications
Introduction
Kecen Zhao is a notable inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for sepsis. His innovative work has the potential to impact clinical practices significantly.
Latest Patents
Kecen Zhao holds 1 patent for his invention titled "Salts of kukoamine B, preparation method and use thereof." This patent details the preparation method and pharmaceutical applications of salts of kukoamine B in the prevention and treatment of sepsis. Experimental results indicate that these salts effectively antagonize key factors that induce sepsis, offering a promising new approach in a field where effective treatments are currently lacking.
Career Highlights
Throughout his career, Kecen Zhao has worked with several prestigious institutions. He has been associated with the First Affiliated Hospital of the Third Military University and Tianjin Chase Sun Pharmaceutical Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Kecen Zhao has collaborated with notable colleagues, including Jiang Zheng and Yuanfeng Zhu. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the pharmaceutical industry.
Conclusion
Kecen Zhao's contributions to the field of pharmaceuticals, particularly in the treatment of sepsis, highlight his role as an innovative inventor. His patent on salts of kukoamine B represents a significant advancement in medical science, offering hope for improved treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile